Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) DMAA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103421854A reveals a green enzymatic route for Duloxetine intermediates, offering high purity and reduced solvent waste for pharmaceutical supply chains.